Clinical Trial Search

Primary: The Effect of Proteins on the Secretion of Gut Hormones From Different Parts of the Gastrointestinal Tract — 1310; 1073; 1118; 1188 pg*min/mL

Primary: Caloric Intake — 531; 465; 444; 494 calories

Primary: Change in Body Weight From Baseline to 12 Months — 1.09; 1.55 lbs

Primary: Change in Alcohol Specific Satiety Score — -0.51; 4.85 score on a scale

Primary: Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women. — 2694; 2537; 2317; 2335 kJ — p=0.2918

Primary: Safety — 4 participants

Primary: Nadir Blood Glucose — 3; 4.4 mmol/l — p=0.008

Primary: Test Meal Energy Intake — 1007.3; 1019.6; 1143.4 kcal — p=<0.01

Primary: Gastric Emptying Half-time (T 1/2) of Solids — 187; 86 minutes — p=<.001

Primary: Change in Craving Score — -0.7; -0.3 score — p=< 0.001

Primary: Total Area Under the Curve (AUC) for Hunger, Fullness, Desire to Eat and Prospective Consumption Using Visual Analog Scales (VAS) — 651; 1008; 638; 640 cm x min — p=<0.05

Primary: Eating Initiation — 250; 270; 245; 250 minutes

Primary: Change in Preference- Liking — 6.5; 4.5 units on a scale

Primary: Dietary Recalls (Calorific Intake) — 1900.9; 2054.3 kcal

Primary: Change in Lipid Content of the Liver (Intrahepatocellular Lipid) — 27.9; 9.3; 21.4; 5.9 % IHCL — p=<0.05

Primary: Subjective Rating of Fear — -36.9444; -23.9219; -47.3611; 85.6250 units on scale*minutes — p=.879

Primary: Food Consumption — 605.5; 404.3; 423.6 weight food eaten g

Primary: Peak Growth Hormone (GH) on the GH Stimulation Test — 40.1; 25.2 ng/ml — p=<0.05

Primary: Glucagon-Like Peptide-1 (GLP-1) — 18; 17 Participants

Primary: Change in Circulating Glucagon-like Peptide-1 (GLP-1) Levels — 7147; 11725; 11898; 28060 pM*min

Primary: Food Consumption After Intervention — 7.9; 7.4 Grams

Primary: Gastric Emptying of Solids Half-Time (T 1/2) — 109; 88 minutes — p=0.057

Primary: Subjective Appetite Ratings in Hunger Compared to Baseline — 4.8; 3.6; 3.6; 4.1 cm — p=0.135

Primary: Total Food Intake (Lunch Buffet) at 24 Months — 2540.1; 721 kJ

Primary: Treatment Emergent Adverse Events — 1; 0; 1; 0 Events

Primary: Total Ghrelin Level — 1063; 1264; 1157 pg/mL

Primary: Change in Weight — -.5 kg — p=.07

Primary: Number of Responses Made by Clicking a Mouse Button for Food — 397.63; 288.36; 429.5; 213.2 Number of button presses

Primary: Difference in Pizza Consumed During Two Meals — 1020.21; 1067.46 calories — p=>0.05

Primary: Number of Participants Who Reported Nausea at 10 Minutes Post Treatment — 17; 18 Participants